Associations between endothelial inflammatory markers and cerebral small vessel disease in a community-based

Zhang Xia1,2, Lingling Jiang1,2, Xueli Cai3

  • 1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Insights

Vascular cell adhesion molecule 1 (VCAM-1) is linked to cerebral small vessel disease (CSVD) presence and severity. Intercellular adhesion molecule 1 (ICAM-1) showed no association with CSVD, indicating VCAM-1

Area of Science:

  • Neuroscience
  • Cardiovascular Science
  • Biomarkers

Background:

  • Endothelial inflammation plays a key role in the pathogenesis of cerebral small vessel disease (CSVD).
  • Vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) are established biomarkers indicating endothelial inflammation.

Purpose of the Study:

  • To investigate the association between VCAM-1 and ICAM-1 levels and the presence and burden of CSVD.
  • To assess the predictive value of these biomarkers for CSVD and cognitive impairment within the CSVD context.

Main Methods:

  • A cross-sectional study involving 2596 community residents from the PRECISE study.
  • Assay of VCAM-1 and ICAM-1 levels in fasting venous blood samples.
  • Assessment of cognitive function using the Montreal Cognitive Assessment (MoCA) and evaluation of CSVD markers (white matter hyperintensity, lacunes, microbleeds, enlarged perivascular spaces) via 3.0T MRI.

Main Results:

  • Elevated VCAM-1 levels were significantly associated with an increased likelihood of CSVD presence (OR=1.16) and higher CSVD burden (cOR=1.11-1.16).
  • VCAM-1 demonstrated improved prediction for CSVD presence and cognition-impaired CSVD.
  • ICAM-1 levels did not show a significant association with CSVD presence or burden, nor did they improve predictive models.

Conclusions:

  • Endothelial inflammation, specifically indicated by elevated VCAM-1, is significantly associated with the presence and increased burden of cerebral small vessel disease.
  • VCAM-1 serves as a potential biomarker for identifying individuals with CSVD and assessing disease severity, whereas ICAM-1 does not appear to be a relevant marker in this context.
Abstract